Impacts of anticancer drug parity laws on mortality rates

Yichen Shen, Haruko Noguchi

研究成果: Article査読

抄録

This study investigates the impacts of anticancer drug parity laws on mortality rates in the United States using a difference-in-differences approach. Using data from 2004 to 2017 Compressed Mortality Files, we show that the anticancer drug parity laws reduce the mortality rate for head/neck malignant cancers but have no impact on malignant cancers of other types. We also rule out an insurance expansion channel that may influence the relationship between anticancer drug parity laws and malignant cancer mortality. Our results are robust to various specifications and falsification tests. Our findings imply that providing equal access to oral anticancer drugs is an effective tool for the prevention of premature mortality.

本文言語English
論文番号113714
ジャーナルSocial Science and Medicine
272
DOI
出版ステータスPublished - 2021 3

ASJC Scopus subject areas

  • Health(social science)
  • History and Philosophy of Science

フィンガープリント 「Impacts of anticancer drug parity laws on mortality rates」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル